سعر سيليبريكس 100 مجم 10 كبسولات 2024

Celebrex 100mg 10 caps.: Celecoxib (Viatris Egypt).

• Osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain, and primary dysmenorrhea as labeled (US CELEBREX/celecoxib capsules).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Common adverse reactions include headache, dyspepsia, upper respiratory infection, diarrhea, and abdominal pain; serious CV and GI events as per boxed warnings (US labeling).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Contraindicated with known hypersensitivity to celecoxib, sulfonamide allergy, aspirin/NSAID-induced asthma/urticaria/allergic-type reactions, and in the setting of CABG surgery (US boxed warning / contraindications).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warnings: increased risk of serious cardiovascular thrombotic events and serious GI bleeding/ulceration/perforation; use lowest effective dose for shortest duration (US CELEBREX/celecoxib labeling).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Anticoagulants / antiplatelets / SSRIsMajorIncreased bleeding risk when combined with anticoagulants, antiplatelets, or SSRIs (US celecoxib labeling).DailyMed (U.S. National Library of Medicine)
• CYP2C9 inhibitors (e.g. fluconazole)ModerateFluconazole and other CYP2C9 inhibitors may increase celecoxib exposure; consider dose reduction (US labeling).DailyMed (U.S. National Library of Medicine)

• Avoid from about 30 weeks of gestation (premature ductus arteriosus closure); oligohydramnios risk from about 20 weeks; use lowest effective dose shortest duration earlier in pregnancy if needed (US CELEBREX/celecoxib labeling, PLLR).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Celecoxib: Inhibits prostaglandin synthesis primarily via cyclooxygenase-2 (COX-2) inhibition; metabolised mainly by CYP2C9.